Cigna Group
For the period ended Sep 30, 2024. Filed Oct 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 31, 2024
CI$293.59-2.6%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Total Equity
| The Cigna Group | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consolidated Statements of Changes in Total Equity | |||||||||||||||||||
| Unaudited | |||||||||||||||||||
| Three Months Ended September 30, 2024 | |||||||||||||||||||
| (In millions) · Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive (Loss) · Retained Earnings · Treasury Stock · Shareholders' Equity · Other Non- controlling Interests · Total Equity · Redeemable Noncontrolling Interests | |||||||||||||||||||
| Balance at June 30, 2024 | $4 | $31,048 | $(2,442) | $42,132 | $(29,410) | $41,332 | $195 | $41,527 | $— | ||||||||||
| Effects of issuing stock for employee benefit plans | 138 | (2) | 136 | 136 | |||||||||||||||
| Other comprehensive income | 279 | 279 | 279 | — | |||||||||||||||
| Net income | 739 | 739 | 86 | 825 | — | ||||||||||||||
| Common dividends declared (per share: $1.40) | (391) | (391) | (391) | ||||||||||||||||
| Repurchase of common stock | — | — | — | — | |||||||||||||||
| Other transactions impacting noncontrolling interests | — | — | (78) | (78) | — | ||||||||||||||
| Balance at September 30, 2024 | $4 | $31,186 | $(2,163) | $42,480 | $(29,412) | $42,095 | $203 | $42,298 | $— | ||||||||||
| Three Months Ended September 30, 2023 | |||||||||||||||||||
| (In millions) | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive (Loss) | Retained Earnings | Treasury Stock | Shareholders' Equity | Other Non- controlling Interests | Total Equity | Redeemable Noncontrolling Interests | ||||||||||
| Balance at June 30, 2023 | $4 | $30,436 | $(1,878) | $39,936 | $(23,053) | $45,445 | $19 | $45,464 | $62 | ||||||||||
| Effect of issuing stock for employee benefit plans | 127 | (5) | 122 | 122 | |||||||||||||||
| Other comprehensive loss | (241) | (241) | (241) | — | |||||||||||||||
| Net income | 1,408 | 1,408 | 4 | 1,412 | 37 | ||||||||||||||
| Common dividends declared (per share: $1.23) | (362) | (362) | (362) | ||||||||||||||||
| Repurchase of common stock | — | (681) | (681) | (681) | |||||||||||||||
| Other transactions impacting noncontrolling interests | — | — | (12) | (12) | (35) | ||||||||||||||
| Balance at September 30, 2023 | $4 | $30,563 | $(2,119) | $40,982 | $(23,739) | $45,691 | $11 | $45,702 | $64 | ||||||||||
| The Cigna Group | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consolidated Statements of Changes in Total Equity | |||||||||||||||||||
| Unaudited | |||||||||||||||||||
| Nine Months Ended September 30, 2024 | |||||||||||||||||||
| (In millions) · Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive (Loss) · Retained Earnings · Treasury Stock · Shareholders' Equity · Other Non- controlling Interests · Total Equity · Redeemable Noncontrolling Interests | |||||||||||||||||||
| Balance at December 31, 2023 | $4 | $30,669 | $(1,864) | $41,652 | $(24,238) | $46,223 | $21 | $46,244 | $107 | ||||||||||
| Effect of issuing stock for employee benefit plans | 517 | (117) | 400 | 400 | |||||||||||||||
| Other comprehensive loss | (299) | (299) | (299) | — | |||||||||||||||
| Net income | 2,010 | 2,010 | 232 | 2,242 | — | ||||||||||||||
| Common dividends declared (per share: $4.20) | (1,182) | (1,182) | (1,182) | ||||||||||||||||
| Repurchase of common stock | — | (5,057) | (5,057) | (5,057) | |||||||||||||||
| Other transactions impacting noncontrolling interests | — | — | (50) | (50) | (107) | ||||||||||||||
| Balance at September 30, 2024 | $4 | $31,186 | $(2,163) | $42,480 | $(29,412) | $42,095 | $203 | $42,298 | $— | ||||||||||
| Nine Months Ended September 30, 2023 | |||||||||||||||||||
| (In millions) | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive (Loss) | Retained Earnings | Treasury Stock | Shareholders' Equity | Other Non- controlling Interests | Total Equity | Redeemable Noncontrolling Interests | ||||||||||
| Balance at December 31, 2022 | $4 | $30,233 | $(1,658) | $37,940 | $(21,844) | $44,675 | $13 | $44,688 | $66 | ||||||||||
| Effect of issuing stock for employee benefit plans | 332 | (110) | 222 | 222 | |||||||||||||||
| Other comprehensive loss | (461) | (461) | (461) | — | |||||||||||||||
| Net income | 4,135 | 4,135 | 14 | 4,149 | 116 | ||||||||||||||
| Common dividends declared (per share: $3.69) | (1,093) | (1,093) | (1,093) | ||||||||||||||||
| Repurchase of common stock | — | (1,785) | (1,785) | (1,785) | |||||||||||||||
| Other transactions impacting noncontrolling interests | (2) | (2) | (16) | (18) | (118) | ||||||||||||||
| Balance at September 30, 2023 | $4 | $30,563 | $(2,119) | $40,982 | $(23,739) | $45,691 | $11 | $45,702 | $64 | ||||||||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.